Publications by authors named "J Javitt"

Claim this Profile
Q
Quality Assurance of Depression Ratings in Psychiatric Clinical Trials.
Michael T Sapko, Cortney Kolesar, Ian R Sharp, Jonathan C Javitt

J Clin Psychopharmacol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NRX-101 (D-Cycloserine + Lurasidone) Is Active against Drug-Resistant Urinary Pathogens In Vitro.
Michael T Sapko, Michael Manyak, Riccardo Panicucci, Jonathan C Javitt

Antibiotics (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NRX-101, a Rapid-Acting Anti-Depressant, Does Not Cause Neurotoxicity Following Ketamine Administration in Preclinical Models.
William Jordan, Michael T Sapko, Richard Siegel, Jonathan Javitt

Int J Toxicol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D-cycloserine is not susceptible to self-administration using an intravenous self-administration model in male ketamine-habituated Sprague-Dawley rats.
Michael T Sapko, Taleen Hanania, Qing Chang, Jonathan C Javitt

Pharmacol Biochem Behav· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis